Axl Recombinant Rabbit Monoclonal Antibody (2H29L9), Invitrogen™

Description

• This antibody is predicted to react with Monkey, Horse, Sheep
• Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems
• The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits
• Then, individual clones are screened to select the best candidates for production
• The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire
• AXL is a chronic myelogenous leukemia-associated oncogene that is also associated with colon cancer and melanoma
• The AXL protein is a receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factors like vitamin K-dependent protein growth-arrest-specific gene 6, and is involved in the stimulation of cell proliferation
• TAM receptors are also involved in phagocytosis of apoptotic cells
• Mice lacking all three TAM receptors have several degenerative phenotypes linked to inefficient removal of apoptotic cells and membranes (e.g., in the retina and the male reproductive tract) and develop a severe autoimmune phenotype akin to systemic lupus erythematosus, including the production of broad spectrum auto-antibodies
• In addition, Axl may function as a putative entry receptor for filoviruses
• Axl is also used to identify a specific subpopulation of human blood dendritic cells, also referred to as Siglec 6+/Axl+ dendritic cells
• Cellular expression of Axl can be upregulated by TLR ligands, such as LPS or poly I:C
• Soluble Axl is generated by proteolytic cleavage of the membrane form
• Increased plasma levels may be indicative of inflammation and cancer.